Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssensys Regulatory News (ESYS)

Share Price Information for Essensys (ESYS)

Share Price is delayed by 15 minutes
Get Live Data
16.75    0.00 (0.00%)
Bid:
16.00
Ask:
17.50
Spread: 1.50 (9.375%)
Market Cap: £11.07m
ESYS Live PriceLast checked at - London Stock Exchange

Intraday Essensys Share Chart

Form 8.5 (EPT/RI)

1 Dec 2025 09:36

RNS Number : 6648J
Canaccord Genuity Limited
01 December 2025
 

-

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Essensys PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected to the Offeree

 

(d) Date dealing undertaken:

28 November 2025

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ord 0.25p

Purchases

3,000

15p

15p

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

Date of disclosure:

01 December 2025

Contact name:

David Baker

Telephone number:

020 7523 4656

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFZMGZLMFGKZG
Date   Source Headline
3rd Aug 20217:00 amRNSAppointment of CEO Asia Pacific
29th Jul 20211:35 pmRNSHolding(s) in Company
28th Jul 20216:15 pmRNSHolding(s) in Company
28th Jul 20216:13 pmRNSHolding(s) in Company
28th Jul 20216:12 pmRNSHolding(s) in Company
27th Jul 20218:50 amRNSDirector/PDMR Shareholding
26th Jul 202110:57 amRNSResults of General Meeting and Open Offer
9th Jul 20214:44 pmRNSOpen Offer Launch, Posting of Circular, GM Notice
9th Jul 20217:00 amRNSResult of Placing
8th Jul 20214:35 pmRNSProposed Fundraising
4th May 202111:44 amRNSHolding(s) in Company
21st Apr 202110:07 amRNSHolding(s) in Company
8th Apr 20217:00 amRNSDirector/PDMR Dealing
23rd Mar 20217:00 amRNSHalf-year Report
16th Mar 20212:00 pmRNSFlex Services Platform launch
10th Mar 202112:37 pmRNSNotice of Investor Meet Company Presentation
10th Mar 20217:00 amRNSNotice of Results
18th Feb 20217:00 amRNSessensys Trading Update - 18.02.2021
16th Feb 20218:28 amRNSHolding(s) in Company
9th Feb 20217:00 amRNSAppointment of Joint Corporate Broker
24th Dec 20209:46 amRNSDirector/PDMR Shareholding
24th Nov 20205:29 pmRNSResult of AGM
4th Nov 20207:00 amRNSAppointment of CEO North America and PDMR Dealing
30th Oct 20205:27 pmRNSPosting of Annual Report and Accounts & AGM Notice
13th Oct 20203:35 pmRNSNotice of Investor Meet Company Presentation
13th Oct 20207:00 amRNSessensys plc - Full Year Results
7th Oct 20207:00 amRNSNotice of Results
24th Aug 20203:09 pmRNSHolding(s) in Company
24th Aug 202011:41 amRNSReplacement: Holding(s) in Company
24th Aug 202010:44 amRNSHolding(s) in Company
18th Aug 20207:00 amRNSTrading Statement
9th Apr 202012:17 pmRNSResult of Placing
9th Apr 20207:01 amRNSProposed placing to raise approximately £7 million
9th Apr 20207:00 amRNSHalf year results
24th Mar 20207:01 amRNSessensys - Market and trading update
18th Feb 20207:00 amRNSTrading Statement
30th Jan 20202:26 pmRNSBoard Appointments and Grant of Options
28th Nov 20191:31 pmRNSResult of Annual General Meeting
1st Nov 20194:30 pmRNSNotice of AGM
22nd Oct 20197:00 amRNSFull Year Results
8th Oct 20197:00 amRNSNotice of Full Year Results
13th Aug 20197:00 amRNSessensys Pre-Close Trading Update
3rd Jun 201912:32 pmRNSHolding(s) in Company
30th May 20192:36 pmRNSHolding(s) in Company
29th May 20192:05 pmRNSSecond Price Monitoring Extn
29th May 20192:00 pmRNSPrice Monitoring Extension
29th May 20197:00 amRNSAdmission to trading on AIM, First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.